Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...

Researchers developed an AI platform that designs drug candidate molecules. The tool incorporates key drug-like traits in its ...

In the world of organic chemistry, nitrogen-containing organic compounds are ubiquitous, forming the backbone of ...

A new study published in the American Society for Microbiology journal Microbiology Spectrum demonstrates that a novel semi-synthetic compound can be derived from natural compounds to produce potent ...

Researchers identified a novel compound aimed at improving the treatment of opioid overdoses. Scientists at the University of Florida have identified a novel compound aimed at improving the treatment ...

Researchers from Drexel University’s College of Arts and Sciences and College of Medicine have found a potential new therapeutic target for Alzheimer’s disease. Expanding on their previous research on ...

A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models. This is the key finding of a recent publication in the Proceedings of the ...

A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models. This is the key finding of a recent publication in the prestigious ...

Researchers have pioneered a new catalytic transformation that converts epoxides into fluorinated oxetanes, a coveted but difficult-to-make class of drug molecules that escaped synthetic preparation ...

"What's particularly exciting is that we found these novel compounds from a single deployment site," said Scripps Oceanography microbiologist Paul Jensen, a co-author of the study, which was funded by ...